Literature DB >> 15758064

Long-term safety of bisphosphonates.

Susan M Ott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15758064     DOI： 10.1210/jc.2005-0057

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  52 in total

1.  Hydroxyapatite-collagen composites. Part I: can the decrease of the interactions between the two components be a physicochemical component of osteoporosis in aged bone?

Authors:  Niccoletta Barbani; Elisabetta Rosellini; Caterina Cristallini; Giulio D Guerra; Adriano Krajewski; Mauro Mazzocchi
Journal:  J Mater Sci Mater Med       Date:  2011-01-30       Impact factor: 3.896

2.  Bisphosphonates in pregnancy and lactation-associated osteoporosis.

Authors:  S M O'Sullivan; A B Grey; R Singh; I R Reid
Journal:  Osteoporos Int       Date:  2006-04-27       Impact factor: 4.507

Review 3.  Pathogenesis of osteoporosis: concepts, conflicts, and prospects.

Authors:  Lawrence G Raisz
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

4.  Pelvic insufficiency fracture associated with severe suppression of bone turnover by alendronate therapy.

Authors:  Kazuhiro Imai; Seizo Yamamoto; Yorito Anamizu; Toshiyuki Horiuchi
Journal:  J Bone Miner Metab       Date:  2007-08-25       Impact factor: 2.626

5.  Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.

Authors:  Sebastian Hoefert; Inge Schmitz; Andrea Tannapfel; Harald Eufinger
Journal:  Clin Oral Investig       Date:  2009-06-18       Impact factor: 3.573

Review 6.  Long-term safety of bisphosphonate therapy for osteoporosis: a review of the evidence.

Authors:  Uri A Liberman
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 7.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

Review 8.  Osteonecrosis of the jaws: clinicopathologic and radiologic characteristics, preventive and therapeutic strategies.

Authors:  Vassilios Vassiliou; Nikolaos Tselis; Dimitrios Kardamakis
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

9.  Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates.

Authors:  J Ward; C Wood; K Rouch; D Pienkowski; H H Malluche
Journal:  Osteoporos Int       Date:  2016-07-22       Impact factor: 4.507

10.  The osteoporosis revolution marches on.

Authors:  Lawrence G Raisz
Journal:  J Orthop Sci       Date:  2007-08-02       Impact factor: 1.601
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.